Pharmos Corporation - PARS - Financial Statement Analysis
All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.
In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.
Financial statement analysis updated: June 16, 2013
Pharmos Corporation - SIC # 2834
| Ticker | Exchange | SIC # | Website | Latest Ticker |
|---|---|---|---|---|
| PARS | Over the counter | 2834 | http://www.pharmoscorp.com | 0.04 0.00 |
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: |
||||
Latest Headlines for Pharmos Corporation
PHARMOS CORP Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Change in Directors or Principal Offi - Jan 2nd, 2013 3:05 pm
PHARMOS CORP Financials - Nov 24th, 2012 11:04 am
PHARMOS CORP Files SEC form 10-Q, Quarterly Report - Nov 19th, 2012 3:20 pm
PHARMOS CORP Files SEC form 8-K, Other Events - Nov 14th, 2012 2:29 pm
Pharmos Announces Levotofisopam for Gout Presented at ACR Meeting - Nov 12th, 2012 12:56 pm
PHARMOS CORP Files SEC form 8-K, Other Events - Oct 17th, 2012 3:01 pm
PHARMOS CORP Files SEC form 10-Q, Quarterly Report - Jul 30th, 2012 4:04 am
PHARMOS CORP Files SEC form 8-K, Financial Statements and Exhibits - May 18th, 2012 4:06 am
View All Current Headlines >> |
||||
